JUNIPER PHARMACEUTICALS INC
DelistedCIK 821995fmd_1YTN6P3P1SZCZYH4STAP33TPB0Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2009 to Jun 30, 2018, 34 periods
| Line item | FY2009 | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 32 | 46 | 43 | 26 | 28 | 33 | 38 | 55 | 50 |
| Cost of revenue | 9 | 9 | 12 | 13 | 13 | 18 | 21 | 24 | 29 |
| Net interest income | – | – | – | 0 | (0) | 0 | 0 | 0 | 0 |
| Gross profit | 23 | 37 | 31 | 13 | 14 | 16 | 17 | 30 | 21 |
| Realized investment gains (losses) | – | – | (0) | 0 | – | – | – | – | – |
| Research and development | 9 | 9 | 3 | 1 | – | 1 | 7 | 10 | 7 |
| Selling, general and administrative | – | – | 8 | – | 8 | 10 | 12 | 15 | 17 |
| Total operating expenses | 36 | 35 | 8 | 10 | 10 | 11 | 19 | 25 | 25 |
| Operating income | (13) | 1 | 23 | 3 | 4 | 5 | (2) | 5 | (4) |
| Interest expense | 9 | 5 | 0 | 0 | – | – | – | – | – |
| Other non-operating income (expense) | (9) | (23) | (2) | 7 | 1 | 1 | 0 | 1 | 2 |
| Income before taxes | (22) | (22) | 21 | 10 | 5 | 5 | (1) | 6 | (2) |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | (0) |
| Net income from continuing operations | (22) | (22) | 21 | 10 | 5 | 5 | (1) | 6 | (2) |
| Net income | (22) | (22) | 21 | 10 | 5 | 5 | (1) | 6 | (2) |
| Net income to common shareholders | – | (22) | 20 | 10 | 5 | 5 | (2) | 6 | (2) |